a. Who and what are you treating?

Review clinical evidence for using cannabis products for your patient’s medical condition.

b. What medicinal cannabis product will you use?

Identify a specific cannabis product (trade name, formulation, route of administration and dose) appropriate for your patient’s medical condition. Identify a GMP-accredited supplier that can provide this cannabis product.

View a list of sponsors authorised to import medicinal cannabis for an Australian stock supply.

TGA approval: Special Access Scheme (SAS)

Submit a Special Access Scheme Category B form to the TGA, which summarises information in Steps 1 A to B.

Check your state and territory requirements

Contact your relevant state/territory department regarding additional requirements for prescribing medicinal cannabis products.

Is the product available in Australia?

If stock is available in Australia, contact the supplier and provide TGA authorisation and state/territory approval (if required).

If the product must be imported from overseas, an import licence and permit must be obtained by the supplier from the Office of Drug Control (ODC).